Methyl glyoxal elevation is associated with oxidative stress in rheumatoid arthritis

Area of Science:

• Biochemistry
• Immunology
• Pathophysiology

Background:

• Methylglyoxal (MG) is a reactive dicarbonyl compound implicated in metabolic dysfunction and disease pathogenesis.
• Oxidative and carbonyl stress are increasingly recognized as significant factors in the development and progression of rheumatoid arthritis (RA).

Purpose of the Study:

• To investigate the role of methylglyoxal (MG) in cellular oxidative and carbonyl stress within rheumatoid arthritis (RA).
• To assess the association between MG levels and oxidative stress markers in RA patients compared to healthy controls.

Main Methods:

• Serum and synovial fluid levels of total antioxidant status (TAS), total thiol, glutathione (GSH), MG, carbonyl compounds, and thiobarbituric acid reactive substances (TBARS) were measured.
• 148 RA patients were categorized into subgroups based on disease severity, RA factor status, and age (acute, remission, seropositive, seronegative, JRA).
• 88 healthy individuals served as the control group.

Main Results:

• Elevated serum MG levels were observed in all RA subgroups compared to normal controls.
• RA patients exhibited increased levels of TBARS and decreased levels of GSH and TAS in both serum and synovial fluid.
• A significant correlation was found between elevated MG and increased TBARS, alongside decreased GSH levels across all RA subgroups.

Conclusions:

• Methylglyoxal (MG) elevation is associated with heightened oxidative stress and diminished antioxidant capacity in rheumatoid arthritis.
• The observed changes suggest that MG contributes to free radical-induced damage, playing a role in the pathophysiology of RA.
• Targeting MG or enhancing antioxidant defenses may represent potential therapeutic strategies for RA.